Skip to main content
Equibles

Fisher Asset Management, LLC

Position in CGON — CG Oncology, Inc.

CIK 850529 PLANO, TX
Back to CGON Full portfolio

Position in CGON

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$32,468,286
+$994,853 QoQ
Shares Held
456,978
-1.7% QoQ
Ownership
0.516%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 35% Shared 0% None 65%

Common Shares in CGON Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Fisher Asset Management, LLC holds $807,507,065 across 59 Biotechnology names. CGON ranks #9 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARWR
Arrowhead Pharmaceuticals, Inc.
 957,691 $78,061,393
2 RCUS
Arcus Biosciences, Inc.
 2,139,396 $65,957,578
3 CYTK
Cytokinetics Inc
 743,697 $63,355,547
4 DNLI
Denali Therapeutics Inc.
 2,414,162 $62,092,246
5 RVMD
Revolution Medicines, Inc.
 207,693 $38,896,745
6 LGND
Ligand Pharmaceuticals Inc
 121,440 $38,385,969
7 CLDX
Celldex Therapeutics, Inc.
 985,677 $36,677,041
8 HALO
Halozyme Therapeutics, Inc.
 427,713 $33,477,096

All Filings in CGON

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,468,286 456,978
2026-03-31 $31,473,433 465,033